PREMIER BIOMEDICAL INC — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/be835c90-b65e-480c-8529-544c19def1e7/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-374.5k | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-005676 |
| FY 2018 | $-398.9k | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-004408 |
| FY 2017 | $-3.8M | 2017-01-01 – 2017-12-31 | evidence 0001477932-18-001754 |
| FY 2016 | $-1.8M | 2016-01-01 – 2016-12-31 | evidence 0001477932-17-002100 |
| FY 2015 | $-2.6M | 2015-01-01 – 2015-12-31 | evidence 0001477932-17-002100 |
| FY 2014 | $-1.4M | 2014-01-01 – 2014-12-31 | evidence 0001477932-15-002010 |
| FY 2013 | $-7.0M | 2010-05-10 – 2014-03-31 | evidence 0001477932-14-002516 |
| FY 2012 | $-4.5M | 2010-05-10 – 2013-03-31 | evidence 0001477932-13-002458 |
| FY 2011 | $-140.9k | 2010-05-10 – 2012-03-31 | evidence 0001477932-12-001656 |
| FY 2010 | $-2.2k | 2010-01-01 – 2010-12-31 | evidence 0001477932-13-001458 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PREMIER BIOMEDICAL INC — all facts · Revenue · Operating Income